These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 14258688)

  • 21. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E; BERG E; KISSMEYER-NIELSEN F
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract]   [Full Text] [Related]  

  • 22. Coagulation patterns in bovine left heart bypass with phospholipid versus heparin surface coating.
    von Segesser LK; Olah A; Leskosek B; Turina M
    ASAIO J; 1993; 39(1):43-6. PubMed ID: 8439679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. THE DEVELOPMENT OF PLATELET FACTOR 3 ACTIVITY BY LATEX PARTICLES--AN INTERACTION WITH PLASMA.
    HOROWITZ HI; MARCUS AJ
    Blood; 1964 Feb; 23():178-85. PubMed ID: 14122242
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of ribonuclease on thrombin inactivation and on the antithrombin activity of heparin in vitro].
    GAERTNER H; LISIEWICZ J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1962; 79():258-71. PubMed ID: 13946076
    [No Abstract]   [Full Text] [Related]  

  • 25. [Pharmacology of heparin].
    Hoffmann A; Markwardt F
    Z Gesamte Inn Med; 1979 Jan; 34(1):3-8. PubMed ID: 373277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. LONG-TERM EFFECTS OF INTERMITTENT LOW DOSES OF HEPARIN ON PLATELET ECONOMY IN MAN.
    MUSTARD JF; GILBERT JB; MURPHY EA
    Lancet; 1965 Mar; 1(7385):575-6. PubMed ID: 14250082
    [No Abstract]   [Full Text] [Related]  

  • 27. EFFECT OF ANIMAL AND VEGETABLE FATS ON BLOOD COAGULATION IN HYPERTENSION PATIENTS.
    ALFEROVA LN
    Fed Proc Transl Suppl; 1963; 22():1143-6. PubMed ID: 14079320
    [No Abstract]   [Full Text] [Related]  

  • 28. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity.
    Manlhiot C; Gruenwald CE; Holtby HM; Brandão LR; Chan AK; Van Arsdell GS; McCrindle BW
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):444-50. PubMed ID: 26553458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update.
    Despotis GJ; Joist JH
    J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [STUDIES ON THE EFFECTS OF MITOMYCIN C AGAINST PATIENTS WITH MALIGNANT TUMORS, PARTICULARLY ON THE CHANGES OF COAGULATING FACTORS].
    YAMADA K
    Naika Hokan; 1964 May; 11():207-16. PubMed ID: 14180228
    [No Abstract]   [Full Text] [Related]  

  • 31. The pharmacology of heparin prophylaxis.
    MacHarg MA; Becht JL
    J Am Vet Med Assoc; 1983 Jul; 183(1):129-30. PubMed ID: 6874519
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of the antithrombin III-heparin-thrombin complex in the defense reaction of the anticoagulation system].
    Kudriashov BA; Liapina LA; Pastorova VE
    Vopr Med Khim; 1988; 34(2):38-42. PubMed ID: 3400189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin.
    Béguin S; Lindhout T; Hemker HC
    Thromb Haemost; 1989 Feb; 61(1):25-9. PubMed ID: 2749591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring complex formation in the blood-coagulation cascade using aptamer-coated SAW sensors.
    Gronewold TM; Glass S; Quandt E; Famulok M
    Biosens Bioelectron; 2005 Apr; 20(10):2044-52. PubMed ID: 15741074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antithrombin activity and prolongation of thrombin time; comparative study of heparin and of some synthetic heparinoids].
    BURSTEIN M; GUINAND A
    Arch Int Pharmacodyn Ther; 1955 Jun; 102(1-2):96-104. PubMed ID: 13239250
    [No Abstract]   [Full Text] [Related]  

  • 37. Localization of the inhibitory site(s) of pentosan polysulphate in blood coagulation.
    Wagenvoord R; Hendrix H; Soria C; Hemker HC
    Thromb Haemost; 1988 Oct; 60(2):220-5. PubMed ID: 2464199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. THE KINETICS OF THROMBIN ACTIVITY IN RECALCIFIED BLOOD PLASMA.
    GRANNIS GF; KAZAL LA; TOCANTINS LM
    Thromb Diath Haemorrh; 1965 Jun; 13():361-72. PubMed ID: 14347860
    [No Abstract]   [Full Text] [Related]  

  • 39. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S; Branda RF; van't Veer C; Cawthern KM; Mann KG
    Thromb Haemost; 2001 Aug; 86(2):660-7. PubMed ID: 11522019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A clotting scheme for 1984.
    Hemker HC; Lindhout T
    Nouv Rev Fr Hematol (1978); 1984; 26(4):227-31. PubMed ID: 6382161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.